dsm-firmenich Animal Nutrition & Health Brings Verax™ Prediction Analytics Application In-House, Accelerating AI and Data-Driven Innovation in Animal Farming

Kaiseraugst (Switzerland)

dsm-firmenich Animal Nutrition & Health (ANH), a global leader in sustainable animal nutrition solutions, today announced it has acquired full ownership of the Verax™ predictive farm analytics platform from InsideTracker.

Over the past seven years, Verax™ has grown into the industry’s only globally deployed early-warning platform that enables integrators and growers to predict and assess animal health status through blood‑based biomarkers.

This milestone marks a significant step in advancing ANH’s artificial intelligence, data analytics, and precision nutrition capabilities that enable animal producers worldwide to improve animal performance, reduce costs, and enhance sustainability outcomes.

Strategic Acquisition and Future Integration

The acquisition allows ANH to integrate Verax™ seamlessly into its Precision Services ecosystem, ensuring full system interoperability—from data capture and model development to farm‑level advisory support. Three InsideTracker colleagues have also joined ANH to enable a smooth transition and continued innovation.

"With Verax™ software fully owned by ANH, we strengthen our data-driven and software competencies, helping farmers identify health and husbandry challenges well in advance, while giving us the freedom to enhance this unique platform and accelerate AI-driven innovation in animal farming," said Ivo Lansbergen, President, Animal Nutrition & Health.

Partnership Origins and Development

The Verax™ journey began in 2019, when ANH and InsideTracker jointly set out to translate human biomarker technology and machine learning into actionable insights for animal farming.

"In 2019 we embarked on a joint endeavour with InsideTracker to develop a blood-based prediction and assessment system for animal production," explained Scott Cavey, Head of Precision Nutrition & Health. "Their technological know‑how and scientific rigor helped shape Verax™ into a robust, credible platform that transforms biomarker data and peer‑reviewed evidence into practical, actionable insights.”

InsideTracker leadership echoed this sentiment.

"The Verax™ partnership originated with a shared vision: to use data as a prediction mechanism to improve animal health and welfare," noted Rony Sellam, CEO of InsideTracker. “dsm-firmenich's expertise in animal science makes it the perfect home for the pioneering insight that Verax™ provides, and an opportunity for InsideTracker to more fully focus on expanding the capabilities of our human health technology platform, Terra."

"We are pleased with the outcome and look forward to seeing the legacy of work together live on, and predictive analytics and artificial intelligence continue to significantly benefit the animal farming industry," continued Sellam.

No changes will occur for existing Verax™ customers; platform support and service continuity are fully assured during the transition.

About dsm-firmenich Animal Nutrition & Health

In 2024, dsm-firmenich shared its plan to find a new owner for the Animal Nutrition & Health (ANH) business, including vitamins. ANH, a dsm-firmenich company, is a global leader in animal nutrition and health, as well as vitamins, carotenoids, and aroma ingredients. ANH is an innovation leader and increased its sales to €3.3 billion with a team of more than 7,800 people, driven by its strong purpose: feeding the planet without costing the earth. Together, we make it possible.

www.dsm-firmenich.com/anh

About InsideTracker

InsideTracker is a leading personal health analytics company using blood biomarkers, AI‑driven insights, and evidence‑based recommendations to optimize human health and performance. The company’s science‑backed platform has been adopted globally across consumer and enterprise wellness programs.

Forward-looking statements

This press release may contain forward-looking statements with respect to dsm-firmenich’s future performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.

Published on

29 June 2026

Tags

  • Press release
  • Precision Service
  • Verax™